Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Meds Apotek AB (publ)OSTO:MEDS +3.90%11 Altman Z-Score is 3.79 as of Jul. 21, 2026, which is 26% below its 10-year median of 5.09. GuruFocus rates OSTO:MEDS with a GF Score™ of 11/100. The stock has 2 warning signs investors should review. Among 1,114 Retail - Cyclical companies, Meds Apotek AB (publ) ranks better than 58.71% on this metric.
The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.
Good Sign:
Altman Z-score of 3.15 is strong.
Meds Apotek AB (publ) has a Altman Z-Score of 3.79, indicating it is in Safe Zones. This implies the Altman Z-Score is strong.
The zones of discrimination were as such:
When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.
The historical rank and industry rank for Meds Apotek AB (publ)'s Altman Z-Score or its related term are showing as below:
OSTO:MEDS'
s Altman Z-Score Range Over the Past 10 Years
Min: 3.15 Med: 5.09 Max: 5.39
Current: 3.15
During the past 4 years, Meds Apotek AB (publ)'s highest Altman Z-Score was 5.39. The lowest was 3.15. And the median was 5.09.
Meds Apotek AB (publ) (OSTO:MEDS) Altman Z-Score Explanation
X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.
X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.
X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.
X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.
X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.
Altman Z-Score does not apply to financial companies.
Meds Apotek AB (publ) Altman Z-Score Related Terms
Meds Apotek AB (publ) Altman Z-Score Historical Data
* Premium members only.
The historical data trend for Meds Apotek AB (publ)'s Altman Z-Score can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:MEDS vs AMZN, BABA, PDD: Altman Z-Score Comparison
For the Internet Retail subindustry, Meds Apotek AB (publ)'s Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Meds Apotek AB (publ) Altman Z-Score vs Retail - Cyclical Industry
For the Retail - Cyclical industry and Consumer Cyclical sector, Meds Apotek AB (publ)'s Altman Z-Score distribution charts can be found below:
* The bar in red indicates where Meds Apotek AB (publ)'s Altman Z-Score falls into.
Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z-Score when X4 or X5 value is 0.
Meds Apotek AB (publ) (OSTO:MEDS) has a Altman Z-Score of 3.79 as of Jul. 21, 2026. The Altman Z-score measures a company's bankruptcy risk. View historical data on Meds Apotek AB (publ) and its competitors. This is 26% below median its historical median of 5.09. Over the past decade, Meds Apotek AB (publ)'s Altman Z-Score has ranged from 3.15 to 5.39. According to the industry distribution chart, Meds Apotek AB (publ) ranks #460 out of 1114 companies in the Retail - Cyclical industry, placing it in the top 41.3%.
Is Meds Apotek AB (publ)'s Altman Z-Score too high?
Meds Apotek AB (publ)'s current Altman Z-Score of 3.79 is 26% below median its 10-year median of 5.09. Over the past 10 years, this metric has ranged from a low of 3.15 to a high of 5.39. The Retail - Cyclical industry median Altman Z-Score is 2.75. Meds Apotek AB (publ)'s value of 3.79 is 37.8% above this industry median. Based on the distribution chart, Meds Apotek AB (publ) ranks #460 out of 1114 companies in the Retail - Cyclical industry, which is above the industry midpoint. Overall, Meds Apotek AB (publ) has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Meds Apotek AB (publ)'s Altman Z-Score compare to AMZN and BABA?
According to the Retail - Cyclical industry distribution chart, Meds Apotek AB (publ) ranks #460 out of 1114 companies for Altman Z-Score. This puts Meds Apotek AB (publ) in the upper half of its industry. The industry median Altman Z-Score is 2.75. Meds Apotek AB (publ)'s value of 3.79 is 37.8% above this benchmark. Historically, Meds Apotek AB (publ)'s own Altman Z-Score has ranged from 3.15 to 5.39 over the past decade. While the company's 10-year median is 5.09 vs. the industry median of 2.75, Meds Apotek AB (publ) has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Altman Z-Score for a Retail - Cyclical company?
The median Altman Z-Score among Retail - Cyclical companies is 2.75, based on 1,114 companies in the industry. Companies in the top quartile (top 25%) have a Altman Z-Score significantly above this median, while those in the bottom quartile fall well below. However, Altman Z-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Meds Apotek AB (publ)'s current Altman Z-Score of 3.79 is 37.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Altman Z-Score mean?
A high Altman Z-Score can signal that a stock is expensive relative to its fundamentals. The Altman Z-score measures a company's bankruptcy risk. View historical data on Meds Apotek AB (publ) and its competitors. For the Retail - Cyclical industry, the median Altman Z-Score is 2.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Meds Apotek AB (publ)'s current Altman Z-Score is 3.79, which is 26% below median its own 10-year median of 5.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Meds Apotek AB (publ) stock overvalued right now?
Meds Apotek AB (publ) (OSTO:MEDS) has a current Altman Z-Score of 3.79. The current Altman Z-Score is 3.79, which is 26% below median its 10-year median of 5.09 and 37.8% above the Retail - Cyclical industry median of 2.75. Meds Apotek AB (publ)'s overall GF Score™ is 11/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Altman Z-Score calculated?
Altman Z-Score is calculated from a company's financial statements. For Meds Apotek AB (publ) (OSTO:MEDS), the current Altman Z-Score is 3.79 as of Jul. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Meds Apotek AB (publ) is a full-scale online pharmacy that sells prescription and over-the-counter medicines with permission from the Medical Products Agency, the Swedish Food Agency and the E-Health Agency. The company's pharmacy products include everything in health, well-being, dietary supplements, beauty products, children's products, fitness products, food and drink and home & household products.
11GF Score
Get the complete analysis for OSTO:MEDS
Altman Z-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:MEDS has been successfully added to your 
